As the global population ages, the Bone Densitometer market is growing at a steady 4.7%. While Dual-Energy X-ray Absorptiometry (DXA) remains the "gold standard" for diagnosing osteoporosis, 2026 has seen a surge in Quantitative Ultrasound (QUS).

QUS is particularly popular in pediatric and rural health because it is radiation-free, portable, and cost-effective. Advanced DXA systems now do more than just measure density; they provide Trabecular Bone Scores (TBS), which evaluate the quality of the bone structure, not just the mass. This allows doctors to identify "fragility" in patients who might have a normal density score but are still at high risk for fractures.